Navigation Links
Poniard Pharmaceuticals Announces Plan for Voluntary Prepayment of Term Loan and Transfer to Nasdaq Capital Market
Date:12/16/2010

SOUTH SAN FRANCISCO, Calif., Dec. 16, 2010 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on innovative oncology therapies, today announced that it has provided notice of voluntary prepayment of its senior secured loan facility to GE Business Financial Services Inc. and Silicon Valley Bank.  The Company expects to pay the approximately $12.3 million balance on the facility, including interest and other fees payable under the loan agreement, prior to year-end.  Once repaid, all covenants and restrictions related to the facility will lift, including lender consent requirements restricting certain asset sales, mergers and acquisition transactions and financial covenants requiring the Company to maintain a minimum amount of unrestricted cash.

The Company also announced today that it received approval from the Nasdaq Stock Market Listing Qualifications Staff to transfer the listing of its common stock from The Nasdaq Global Market to The Nasdaq Capital Market.  This transfer will be effective at the opening of business on Friday, December 17, 2010, and the Company's common stock will continue to trade under the symbol "PARD."  The Nasdaq Capital Market is a continuous trading market that operates in substantially the same manner as The Nasdaq Global Market.  All companies listed on The Nasdaq Capital Market must meet certain financial requirements and comply with Nasdaq's corporate governance requirements.

"The steps taken today serve to free up capital and assets as well as maintain the continued liquidity of our common stock and Nasdaq listing status as we continue our ongoing review of strategic alternatives aimed at optimizing the value of the Company and of our lead program, picoplatin," said Ronald A. Martell, chief executive officer of Poniard Pharmaceuticals.  "We continue t
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Poniard Pharmaceuticals Reports Third Quarter 2010 Financial Results
2. Poniard Pharmaceuticals Awarded $244,479 Grant Under Qualifying Therapeutic Discovery Project Program
3. Poniard Pharmaceuticals Receives NASDAQ Deficiency Notice Related to Minimum Bid Price
4. Poniard Announces Final Data from Phase 3 SPEAR Trial of Picoplatin in Small Cell Lung Cancer
5. Poniard Pharmaceuticals Announces $6.3 Million Financing
6. Poniard Pharmaceuticals Secures $20 Million Committed Equity Financing Facility
7. Poniard Pharmaceuticals to Present at 12th Annual BIO CEO and Investor Conference
8. Poniard Pharmaceuticals Announces Management Changes and Reduction in Force
9. Poniard Pharmaceuticals Announces Phase 2 Trial of Picoplatin in Metastatic Colorectal Cancer Meets Primary Endpoint and Study Objectives
10. Poniard Pharmaceuticals Announces Updated Positive Clinical Data from Phase 2 Trial of Picoplatin in Colorectal Cancer and New Phase 1 Cardiac Safety Trial Results
11. Poniard Pharmaceuticals Announces Positive Cardiac Safety Data From Picoplatin Phase 1 Trial Supporting NDA Filing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... , May 6, 2015 In ... malaria and tuberculosis combined[1]. Approximately 40 percent of cancer cases ... the right treatment[3]. Together with Elekta, ministries of health in ... their radiation therapy infrastructures and save lives. More ... from radiation therapy[4] during the course of their disease, either ...
(Date:5/6/2015)... May 06, 2015 Research and Markets ... of the "Asia-Pacific Internal Trauma Fixation Devices ... and Forecast To 2019" report to their ... Devices market is estimated to grow at a ... such as technological advancement, rising incidences of road ...
(Date:5/6/2015)... , May 6, 2015   GenSpera, Inc. ... Compositions" has entered the national phase application process in 17 ... Japan , China , ... States . When awarded, the resulting patent application will ... its entire platform technology, including its lead drug candidate, mipsagargin, ...
Breaking Medicine Technology:Elekta to bring cancer treatment to millions in Africa 2Elekta to bring cancer treatment to millions in Africa 3Elekta to bring cancer treatment to millions in Africa 4Asia-Pacific Internal Trauma Fixation Devices (Internal Trauma Fixation Plates, Screws, Rod Wires & Pins, Fusion Nails) Market 2015 2GenSpera Enters National Phase with Patent Application for Injectable Prodrug Formulations 2
(Date:5/6/2015)... A quality built chicken coop condo with a wheel ... to raise chickens on a pasture. By installing a wheel ... have a chicken tractor that stands up to being moved around ... it is able to flex to uneven ground without losing its ... are fertilized, and it will help provide the chickens with fresh ...
(Date:5/6/2015)... The Canton Group is joining Lardarius Webb ... charity softball game. The event takes place on Friday, May ... years guests include Joe Flacco, John Harbaugh, Ed Reed and ... if you are interested in attending. , The Canton ... SOAR Baltimore and The CollegeBound Foundation , ...
(Date:5/6/2015)... 06, 2015 Animals make just as good ... also good for your health. An Ohio veterinarian ... increase he's seeing with health advantages of owning a pet. ... it comes to pet ownership, there are proven health benefits ... Scott Leffler of the Animal Medical Center of ...
(Date:5/6/2015)... Anitha Nallari, MD has joined ... Inc. in Columbus, OH. Dr. Nallari will see patients ... in breast cancer, lung cancer, GI and gallbladder cancer, head ... benign hematology. , Dr. Anitha Nallari is Board ... American Board of Internal Medicine. She completed her medical education ...
(Date:5/6/2015)... May 06, 2015 Anitoa Systems, (“Anitoa”), ... with Zhejiang University of China, has successfully demonstrated a ... CMOS bio-optical sensor. Anitoa’s handheld qPCR is shown ... DNA and RNA’s, including hepatitis B, C, and E. ... 4 copies per sample and over 9 orders of ...
Breaking Medicine News(10 mins):Health News:Chicken Coop Condo Launches the Chicken Tractor 2Health News:The Canton Group Sponsors Ravens Charity Softball Event 2Health News:The Canton Group Sponsors Ravens Charity Softball Event 3Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 2Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 3Health News:New Oncologist to Join Hematology Oncology Consultants, Inc. 2Health News:New Oncologist to Join Hematology Oncology Consultants, Inc. 3Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 2Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 3
... NY The American Cancer Society and the National Palliative ... grants to researchers at 12 institutions for studies aimed at ... The studies will be conducted over the next two years. ... 51 grants totaling almost $7 million. These grants, which are ...
... ... first in the Albany, NY area to have Laser-Assisted Smartlipo Triplex™ technology to offer ... and faster healing times. , ... Albany-Schenectady-Troy, NY (PRWEB) May 12, 2010 -- Traditional liposuction has been available ...
... doses of metformin, Avandia cut risk by two-thirds in study, ... pre-diabetes, a low-dose combination of two diabetes drugs -- metformin ... type 2 diabetes, new research shows. , The study found ... by two-thirds in those taking the drug combo compared to ...
... between 18 and 25, researchers say , WEDNESDAY, June 2 ... what they believe -- or hope -- is true: Teenagers ... study found that as teens become young adults, many -- ... impulsive behaviors decreases, along with the amount of alcohol they ...
... be tailored to individual patients, researchers say , , WEDNESDAY, ... can benefit from deep brain stimulation in either one of ... The Veterans Affairs researchers compared two different targets in the ... and the globus pallidus interna (GPi) -- both of which ...
... very few if any, really know how likely they are ... to change, thanks to a new discovery by an international ... access people,s personal risk for skin cancer. In ... Journal ( http://www.fasebj.org ), these researchers describe for the ...
Cached Medicine News:Health News:$1.8 million awarded for palliative care research to improve care of seriously ill patients 2Health News:$1.8 million awarded for palliative care research to improve care of seriously ill patients 3Health News:$1.8 million awarded for palliative care research to improve care of seriously ill patients 4Health News:$1.8 million awarded for palliative care research to improve care of seriously ill patients 5Health News:Breakthrough In Liposuction Comes To New York's Capital District 2Health News:Drug Combo Staves Off Type 2 Diabetes 2Health News:Drug Combo Staves Off Type 2 Diabetes 3Health News:Impulsive Behavior, Drinking Decline in Early Adulthood 2Health News:Deep Brain Stimulation Works in Two Sites for Parkinson's Disease 2Health News:Deep Brain Stimulation Works in Two Sites for Parkinson's Disease 3Health News:Sun-induced skin cancer: new discovery permits doctors to assess genetic risk 2
... Rigid plastic. Convenient. Single use. Kit comprises: 1 ... 2 Child; Miller 3 Medium Ad.; 1 Mac 2 ... Large Ad. 1 Chrome Handle, Standard, 1 Nylon Carrying ... sturdy yet lightweight way to take your disposable laryngoscopes ...
... Lamp supplied with blade. Oxygen port. ... on any standard/conventional handle allowing you ... without the potential confusion from different ... offer an easy and cost effective ...
... disposable blades are an economical option ... labor by requiring no sterilization, disinfecting, ... disposable blades help eliminate cross-contamination., ... concern for possible crosscontamination from AIDS, ...
... Medical's Articulating Tip Laryngoscopes are ... the Industry. The articulating tip ... providing an improved view of ... Fiber Optic styles. We guarantee ...
Medicine Products: